FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jörg Beyer

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
J Schirren; Stephan Trainer; Jörg Beyer; Michael Eberlein; Anja Lorch; S Bölükbas
The role of residual tumor resection in the management of nonseminomatous germ cell cancer of testicular origin.
Anja Lorch; Oliver Rick; Carsten Bokemeyer; Jörg T Hartmann; Antje Kleinhans; Christian K Kollmannsberger; Andrew Kramar; Jörg Beyer
Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial.
Thomas Burmeister; Birte Friedrichs; Nils Lachmann; Gunnar Lohm; Rolf Marschalek; Claus Meyer; Mara Molkentin; Stefan Schwartz; Carola Tietze-Bürger; Jörg Beyer; Igor Wolfgang Blau; Lutz Uharek
Molecular monitoring of minimal residual disease in two patients with MLL-rearranged acute myeloid leukemia and haploidentical transplantation after relapse.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jörg Beyer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: J Schirren; Stephan Trainer; Jörg Beyer; Michael Eberlein; Anja Lorch; S Bölükbas
The role of residual tumor resection in the management of nonseminomatous germ cell cancer of testicular origin.
The Thoracic and cardiovascular surgeon 2012;60(6):405-12.
2012: Anja Lorch; Oliver Rick; Carsten Bokemeyer; Jörg T Hartmann; Antje Kleinhans; Christian K Kollmannsberger; Andrew Kramar; Jörg Beyer
Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(8):800-5.
2012: Thomas Burmeister; Birte Friedrichs; Nils Lachmann; Gunnar Lohm; Rolf Marschalek; Claus Meyer; Mara Molkentin; Stefan Schwartz; Carola Tietze-Bürger; Jörg Beyer; Igor Wolfgang Blau; Lutz Uharek
Molecular monitoring of minimal residual disease in two patients with MLL-rearranged acute myeloid leukemia and haploidentical transplantation after relapse.
Experimental hematology & oncology 2012;1(1):6.
2011: Alan Horwich; Jörg Beyer; Gedske Daugaard; Christian Kollmannsberger; Michael A S Jewett
Salvage therapy: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009.
Urology 2011;78(4 Suppl):S469-74.
2011: A Lorch; C Winter; P Albers; Jörg Beyer
[High-dose chemotherapy and residual tumor resection in male germ cell tumors].
Der Urologe. Ausg. A 2011;50(9):1047-54.
2011: Anja Lorch; Caroline Bascoul-Mollevi; Andrew Kramar; Lawrence Einhorn; Andrea Necchi; Christophe Massard; Ugo De Giorgi; Aude Fléchon; Kim Margolin; Jean-Pierre Lotz; Jose Ramon Germà-Lluch; Thomas Powles; Christian Kollmannsberger; Jörg Beyer
Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(16):2178-84.
2011: Rainer Souchon; Michael Hartmann; Susanne Krege; Anja Lorch; Frank Mayer; Maria De Santis; Silke Gillessen; Jörg Beyer; Richard Cathomas
Interdisciplinary evidence-based recommendations for the follow-up of early stage seminomatous testicular germ cell cancer patients.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2011;187(3):158-66.
2011: Darren R Feldman; Jörg Beyer; Emma Hall; Robert Huddart; Thomas Powles
Is high dose therapy superior to conventional dose therapy as initial treatment for relapsed germ cell tumors? The TIGER Trial.
Journal of Cancer 2011;2():374-7.
2010: Anja Lorch; Jörg Beyer; Caroline Bascoul-Mollevi; Andrew Kramar; Lawrence H Einhorn; Andrea Necchi; Christophe Massard; Ugo De Giorgi; Aude Fléchon; Kim A Margolin; Jean-Pierre Lotz; Jose Ramon Germa Lluch; Thomas Powles; Christian K Kollmannsberger
Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(33):4906-11.
2010: Anja Lorch; Oliver Rick; Thomas Wündisch; Jörg-Thomas Hartmann; Carsten Bokemeyer; Jörg Beyer
High dose chemotherapy as salvage treatment for unresectable late relapse germ cell tumors.
The Journal of urology 2010;184(1):168-73.
2010: Richard Cathomas; Daniel Helbling; Frank Stenner; Christian Rothermundt; Cyrill Rentsch; Osama Shahin; Hans-Helge Seifert; Kathrin Zaugg; Anja Lorch; Frank Mayer; Jörg Beyer; Maria De Santis; Silke Gillessen
Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effort.
Swiss medical weekly 2010;140(25-26):356-69.
2010: A Lorch; A Neubauer; M Hackenthal; A Dieing; J T Hartmann; O Rick; C Bokemeyer; Jörg Beyer
High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(4):820-5.
2010: Karin Oechsle; Anja Lorch; Friedemann Honecker; Christian Kollmannsberger; Jörg T Hartmann; Ina Boehlke; Jörg Beyer; Carsten Bokemeyer
Patterns of relapse after chemotherapy in patients with high-risk non-seminomatous germ cell tumor.
Oncology 2010;78(1):47-53.
2009: Christian Kollmannsberger; Jörg Beyer; Carsten Bokemeyer
High-dose chemotherapy in nonseminomatous germ cell cancer.
BJU international 2009;104(9 Pt B):1398-403.
2009: A Lorch; K Oechsle; C Bokemeyer; Jörg Beyer
[Salvage treatment in germ cell tumors : high-dose chemotherapy and the impact of prognostic factors].
Der Urologe. Ausg. A 2009;48(4):364-71.
2008: Susanne Krege; Jörg Beyer; Rainer Souchon; Peter Albers; Walter Albrecht; Ferran Algaba; Michael Bamberg; István Bodrogi; Carsten Bokemeyer; Eva Cavallin-Ståhl; Johannes Classen; Christoph Clemm; Gabriella Cohn-Cedermark; Stéphane Culine; Gedske Daugaard; Pieter H M De Mulder; Maria De Santis; Maike de Wit; Ronald de Wit; Hans Günter Derigs; Klaus-Peter Dieckmann; Annette Dieing; Jean Pierre Droz; Martin Fenner; Karim Fizazi; Aude Flechon; Sophie D Fosså; Xavier Garcia del Muro; Thomas Gauler; Lajos Geczi; Arthur Gerl; Jose Ramon Germa-Lluch; Silke Gillessen; Jörg T Hartmann; Michael Hartmann; Axel Heidenreich; Wolfgang Hoeltl; Alan Horwich; Robert Huddart; Michael Jewett; Johnathan Keith Joffe; William G Jones; László Kisbenedek; Olbjørn Klepp; Sabine Kliesch; Kai Uwe Koehrmann; Christian Kollmannsberger; Markus Kuczyk; Pilar Laguna; Oscar Leiva Galvis; Volker Loy; Malcolm D Mason; Graham M Mead; Rolf Mueller; Craig Nichols; Nicola Nicolai; Tim Oliver; Dalibor Ondrus; Gosse O N Oosterhof; Luis Paz Ares; Giorgio Pizzocaro; Jörg Pont; Tobias Pottek; Tom Powles; Oliver Rick; Giovanni Rosti; Roberto Salvioni; Jutta Scheiderbauer; Hans-Ulrich Schmelz; Heinz Schmidberger; Hans-Joachim Schmoll; Mark Schrader; Felix Sedlmayer; Niels E Skakkebaek; Aslam Sohaib; Sergei Tjulandin; Padraig Warde; Stefan Weinknecht; Lothar Weissbach; Christian Wittekind; Eva Winter; Lori Wood; Hans von der Maase
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I.
European urology 2008;53(3):478-96.
2008: Susanne Krege; Jörg Beyer; Rainer Souchon; Peter Albers; Walter Albrecht; Ferran Algaba; Michael Bamberg; István Bodrogi; Carsten Bokemeyer; Eva Cavallin-Ståhl; Johannes Classen; Christoph Clemm; Gabriella Cohn-Cedermark; Stéphane Culine; Gedske Daugaard; Pieter H M De Mulder; Maria De Santis; Maike de Wit; Ronald de Wit; Hans Günter Derigs; Klaus-Peter Dieckmann; Annette Dieing; Jean Pierre Droz; Martin Fenner; Karim Fizazi; Aude Flechon; Sophie D Fosså; Xavier Garcia del Muro; Thomas Gauler; Lajos Geczi; Arthur Gerl; Jose Ramon Germa-Lluch; Silke Gillessen; Jörg T Hartmann; Michael Hartmann; Axel Heidenreich; Wolfgang Hoeltl; Alan Horwich; Robert Huddart; Michael Jewett; Johnathan Keith Joffe; William G Jones; László Kisbenedek; Olbjørn Klepp; Sabine Kliesch; Kai Uwe Koehrmann; Christian Kollmannsberger; Markus Kuczyk; Pilar Laguna; Oscar Leiva Galvis; Volker Loy; Malcolm D Mason; Graham M Mead; Rolf Mueller; Craig Nichols; Nicola Nicolai; Tim Oliver; Dalibor Ondrus; Gosse O N Oosterhof; Luis Paz-Ares; Giorgio Pizzocaro; Jörg Pont; Tobias Pottek; Tom Powles; Oliver Rick; Giovanni Rosti; Roberto Salvioni; Jutta Scheiderbauer; Hans-Ulrich Schmelz; Heinz Schmidberger; Hans-Joachim Schmoll; Mark Schrader; Felix Sedlmayer; Niels E Skakkebaek; Aslam Sohaib; Sergei Tjulandin; Padraig Warde; Stefan Weinknecht; Lothar Weissbach; Christian Wittekind; Eva Winter; Lori Wood; Hans von der Maase
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II.
European urology 2008;53(3):497-513.
2008: C Sammler; Jörg Beyer; C Bokemeyer; J T Hartmann; O Rick
Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.
European journal of cancer (Oxford, England : 1990) 2008;44(2):237-43.
2007: Jörg Thomas Hartmann; Thomas Gauler; Bernd Metzner; Arthur Gerl; Jochen Casper; Oliver Rick; Marius Horger; Jan Schleicher; Günter Derigs; Regine Mayer-Steinacker; Jörg Beyer; Markus A Kuczyk; Carsten Bokemeyer
Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(36):5742-7.
2007: Anja Lorch; Jörg Beyer; Carsten Bokemeyer
Germ-cell tumors.
The New England journal of medicine 2007;357(17):1772-3; author reply 1773-4.
2007: Anja Lorch; Christian Kollmannsberger; Jörg Thomas Hartmann; Bernd Metzner; Ingo G H Schmidt-Wolf; Wolfgang E Berdel; Florian Weissinger; Jan Schleicher; Gerlinde Egerer; Antje Haas; Rebekka Schirren; Jörg Beyer; Carsten Bokemeyer; Oliver Rick
Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(19):2778-84.
2007: L Weissbach; Jörg Beyer
[High-dose chemotherapy and hematopoietic stem cell transplantation in patients with germ cell cancer].
Der Urologe. Ausg. A 2007;46(4):416-9.
2006: O Rick; T Braun; W Siegert; Jörg Beyer
Activity of thalidomide in patients with platinum-refractory germ-cell tumours.
European journal of cancer (Oxford, England : 1990) 2006;42(12):1775-9.
2006: Susanne Krege; C Boergermann; R Baschek; A Hinke; Tobias Pottek; Sabine Kliesch; Klaus-Peter Dieckmann; Peter Albers; B Knutzen; Stefan Weinknecht; HJ Schmoll; Jörg Beyer; H Ruebben
Single agent carboplatin for CS IIA/B testicular seminoma. A phase II study of the German Testicular Cancer Study Group (GTCSG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(2):276-80.
2005: Matthias Stelljes; Martin Bornhauser; Matthias Kroger; Jörg Beyer; Maria Cristina Sauerland; Achim Heinecke; Bjorna Berning; christian scheffold; Gerda Silling; Thomas Buchner; Andreas Neubauer; Axel A Fauser; Gerhard Ehninger; Wolfgang E Berdel; Joachim Kienast
Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
Blood 2005;106(9):3314-21.
2005: Nicolaus Kröger; Bronwen Shaw; Simona Iacobelli; Tatjana Zabelina; Karl S Peggs; Avichai Shimoni; Arnon Nagler; Thomas Binder; Thomas Eiermann; Alejandro Madrigal; Rainer Schwerdtfeger; Michael Kiehl; Herbert G Sayer; Jörg Beyer; Martin Bornhäuser; Francis Ayuk; Axel R Zander; David I Marks
Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma.
British journal of haematology 2005;129(5):631-43.
2005: Markus Kuczyk; Marcus Horstmann; Axel S Merseburger; Jörg Beyer
[Therapy for recurrent testicular cancer].
Der Urologe. Ausg. A 2005;44(4):352-7.
2005: Axel Heidenreich; Carsten-Henning Ohlmann; Axel Hegele; Jörg Beyer
Repeat retroperitoneal lymphadenectomy in advanced testicular cancer.
European urology 2005;47(1):64-71.
2005: Christian Görg; B Wollenberg; Jörg Beyer; Manfred Stolte; Andreas Neubauer
High-resolution ultrasonography in gastrointestinal graft-versus-host disease.
Annals of hematology 2005;84(1):33-9.
2004: Jörg Beyer; C Bokemeyer
[Chemotherapy for germ cell cancer].
Der Urologe. Ausg. A 2004;43(12):1507-13.
2004: Nicolaus Kröger; Jose A Perez-Simon; Han Myint; Hans Klingemann; Avichai Shimoni; Arnon Nagler; Rodrigo Martino; Adrian Alegre; Jose F Tomas; Rainer Schwerdtfeger; Michael Kiehl; Axel A Fauser; Herbert G Sayer; Angel Leon; Jörg Beyer; Tatjana Zabelina; Francis Ayuk; Jesús F San Miguel; Ronald Brand; Axel R Zander
Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(10):698-708.
2004: Oliver Rick; Carsten Bokemeyer; Stefan Weinknecht; J Schirren; Tobias Pottek; Jörg Thomas Hartmann; T Braun; B Rachud; Lothar Weissbach; Michael Hartmann; Wolfgang Siegert; Jörg Beyer
Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(18):3713-9.
2004: H J Schmoll; R Souchon; S Krege; P Albers; Jörg Beyer; C Kollmannsberger; S D Fossa; N E Skakkebaek; R de Wit; K Fizazi; J P Droz; G Pizzocaro; G Daugaard; P H M de Mulder; A Horwich; T Oliver; R Huddart; G Rosti; L Paz Ares; O Pont; J T Hartmann; N Aass; F Algaba; M Bamberg; I Bodrogi; C Bokemeyer; J Classen; S Clemm; S Culine; Maike de Wit; H G Derigs; K P Dieckmann; M Flasshove; X Garcia del Muro; A Gerl; J R Germa-Lluch; M Hartmann; A Heidenreich; W Hoeltl; Johnathan Keith Joffe; W Jones; G Kaiser; O Klepp; S Kliesch; L Kisbenedek; K U Koehrmann; M Kuczyk; M P Laguna; O Leiva; Volker Loy; M D Mason; G M Mead; R P Mueller; N Nicolai; G O N Oosterhof; T Pottek; O Rick; H Schmidberger; F Sedlmayer; W Siegert; U Studer; S Tjulandin; H von der Maase; P Walz; S Weinknecht; L Weissbach; E Winter; Christian Wittekind
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(9):1377-99.
2004: Oliver Rick; Christian Kollmannsberger; Jörg Thomas Hartmann; T Braun; Wolfgang Siegert; Carsten Bokemeyer; Jörg Beyer
The role of high-dose chemotherapy in relapsed germ cell tumors.
World journal of urology 2004;22(1):25-32.
2004: Alexander Claviez; Thomas Klingebiel; Jörg Beyer; Wenzel Nürnberger; Gerhard Ehninger; Meinolf Suttorp; Peter Dreger; Wolfgang Dörffel; Norbert Schmitz
Allogeneic peripheral blood stem cell transplantation following fludarabine-based conditioning in six children with advanced Hodgkin's disease.
Annals of hematology 2004;83(4):237-41.
2004: Christian Kollmannsberger; Jörg Beyer; R Liersch; P Schoeffski; Bernd Metzner; Jörg Thomas Hartmann; Oliver Rick; K Stengele; K Hohloch; C Spott; Lothar Kanz; Carsten Bokemeyer
Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):108-14.
2003: Jörg Beyer; Andreas Frewer; Johannes Gobertus Meran
Ethics in oncology. Stormy weather ahead, but also the promise of a better world.
Onkologie 2003;26(6):522-3.
2003: Hans-J Schmoll; Christian Kollmannsberger; Bernd Metzner; Jörg Thomas Hartmann; Norbert Schleucher; Patrick Schöffski; Jan Schleicher; Oliver Rick; Jörg Beyer; Dieter K Hossfeld; Lothar Kanz; Wolfgang E Berdel; Reinhard Andreesen; Carsten Bokemeyer
Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(22):4083-91.
2003: Markus Ritter; Joachim Schwedler; Jörg Beyer; Kamran Movassaghi; Reinier Mutters; Andreas Neubauer; Nimrod Schwella
Bacterial contamination of ex vivo processed PBPC products under clean room conditions.
Transfusion 2003;43(11):1587-95.
2003: Achim Aigner; P Brachmann; Jörg Beyer; Robert Jäger; Daniel Raulais; Marc Vigny; Andreas Neubauer; A Heidenreich; S Weinknecht; Frank Czubayko; Gerhard Zugmaier
Marked increase of the growth factors pleiotrophin and fibroblast growth factor-2 in serum of testicular cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(10):1525-9.
2003: Hermann Einsele; Hartmut Bertz; Jörg Beyer; Michael Kiehl; Volker Runde; Hans-Jochen Kolb; Ernst Holler; Robert Beck; Rainer Schwerdfeger; Ulrike Schumacher; Holger Hebart; Hans Martin; Joachim Kienast; Andrew J Ullmann; Georg Maschmeyer; William Krüger; Dietger Niederwieser; Hartmut Link; Christian A Schmidt; Helmut Oettle; Thomas Klingebiel
Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Annals of hematology 2003;82 Suppl 2():S175-85.
2003: Oliver Rick; Christian Kollmannsberger; Jörg Beyer; Carsten Bokemeyer
Current aspects of high-dose chemotherapy in germ-cell tumors.
Critical reviews in oncology/hematology 2003;47(3):237-48.
2003: Johannes Schetelig; Christian Thiede; Martin Bornhauser; Rainer Schwerdtfeger; Michael Kiehl; Jörg Beyer; Herbert G Sayer; N Kroger; M Hensel; christian scheffold; Thomas K Held; K Hoffken; A D Ho; Joachim Kienast; Andreas Neubauer; Axel R Zander; Axel A Fauser; Gerhard Ehninger; Wolfgang Siegert
Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(14):2747-53.
2003: Herbert G Sayer; Matthias Kröger; Jörg Beyer; Michael Kiehl; S A Klein; K Schaefer-Eckart; Rainer Schwerdtfeger; Wolfgang Siegert; Volker Runde; Catrin Theuser; H Martin; Johannes Schetelig; D W Beelen; Axel A Fauser; Joachim Kienast; Klaus Höffken; Gerhard Ehninger; Martin Bornhäuser
Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor.
Bone marrow transplantation 2003;31(12):1089-95.
2003: Nicolaus Kröger; Martin Bornhäuser; Gerhard Ehninger; Rainer Schwerdtfeger; H Biersack; Herbert G Sayer; Hannes Wandt; K Schäfer-Eckardt; Jörg Beyer; Michael Kiehl; Axel R Zander
Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
Annals of hematology 2003;82(6):336-42.
2003: Christian Kollmannsberger; Norbert Schleucher; Oliver Rick; Bernd Metzner; Jörg Thomas Hartmann; Patrick Schöffski; Jörg Beyer; Jochen Casper; M Sosada; Hans-J Schmoll; I Böhlke; Christoph Meisner; Lothar Kanz; Carsten Bokemeyer
Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell support.
European journal of cancer (Oxford, England : 1990) 2003;39(6):775-82.
2003: Carsten Bokemeyer; Jörg Thomas Hartmann; Sophie D Fossa; Jean Pierre Droz; Hans-J Schmol; Alan Horwich; Arthur Gerl; Jörg Beyer; Jörg Pont; Lothar Kanz; Craig Nichols; Lawrence Einhorn
Extragonadal germ cell tumors: relation to testicular neoplasia and management options.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2003;111(1):49-59; discussion 59-63.
2002: Oliver Rick; Jörg Beyer; Nimrod Schwella; Wolfgang Siegert
Influence of amifostine on reconstitution of lymphocyte subpopulations after conventional- and high-dose chemotherapy in patients with germ cell tumor.
Annals of hematology 2002;81(12):717-22.
2002: Oliver Rick; Wolfgang Siegert; Nimrod Schwella; Marc Dubiel; Andreas Krusch; Jörg Beyer
High-dose chemotherapy as salvage treatment for seminoma.
Bone marrow transplantation 2002;30(3):157-60.
2002: Jörg Thomas Hartmann; Craig Nichols; Jean Pierre Droz; Alan Horwich; Arthur Gerl; Sophie D Fossa; Jörg Beyer; Jörg Pont; Lothar Kanz; Lawrence Einhorn; Carsten Bokemeyer
Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(7):1017-28.
2002: Charlotte Kloft; Wolfgang Siegert; Jörg Beyer; Ulrich Jaehde
Toxicity of high-dose carboplatin: ultrafiltered and not total plasma pharmacokinetics is of clinical relevance.
Journal of clinical pharmacology 2002;42(7):762-73.
2002: Christian Kollmannsberger; Oliver Rick; Hans Günter Derigs; Norbert Schleucher; Patrick Schöffski; Jörg Beyer; R Schoch; H G Sayer; Arthur Gerl; Markus Kuczyk; C Spott; Lothar Kanz; Carsten Bokemeyer
Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(8):2031-7.
2002: Jörg Beyer; Sally P Stenning; Arthur Gerl; Sophie D Fossa; Wolfgang Siegert
High-dose versus conventional-dose chemotherapy as first-salvage treatment in patients with non-seminomatous germ-cell tumors: a matched-pair analysis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(4):599-605.
2002: Carsten Bokemeyer; Craig Nichols; Jean Pierre Droz; Hans-J Schmoll; Alan Horwich; Arthur Gerl; Sophie D Fossa; Jörg Beyer; Jörg Pont; Lothar Kanz; Lawrence Einhorn; Jörg Thomas Hartmann
Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(7):1864-73.
2002: Johannes Schetelig; Christian Thiede; Martin Bornhäuser; Rainer Schwerdtfeger; Michael Kiehl; Jörg Beyer; Nicolaus Kröger; M Hensel; christian scheffold; A D Ho; Joachim Kienast; Andreas Neubauer; Axel R Zander; Axel A Fauser; Gerhard Ehninger; Wolfgang Siegert
Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemia.
Annals of hematology 2002;81 Suppl 2():S47-8.
2002: Jörg Beyer; A Frewer; D Kingreen; Johannes Gobertus Meran
["Science between sponsorship and corruption"].
Wiener medizinische Wochenschrift (1946) 2002;152(9-10):233.
2001: Jörg Thomas Hartmann; Sophie D Fossa; Craig Nichols; Jean Pierre Droz; Alan Horwich; Arthur Gerl; Jörg Beyer; Jörg Pont; Karim Fizazi; H Hecker; Lothar Kanz; Lawrence Einhorn; Carsten Bokemeyer
Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors.
Journal of the National Cancer Institute 2001;93(22):1733-8.
2001: Hermann Einsele; Hartmut Bertz; Jörg Beyer; Michael Kiehl; Volker Runde; H J Kolb; E Holler; R Beck; R Schwerdfeger; U Schumacher; Holger Hebart; H Martin; Joachim Kienast; A J Ullmann; Georg Maschmeyer; William Krüger; H Link; Christian A Schmidt; Helmut Oettle; T Klingebiel
[Epidemiology and interventional treatment strategies of infectious complications after allogenic stem-cell transplantation].
Deutsche medizinische Wochenschrift (1946) 2001;126(45):1278-84.
2001: Oliver Rick; Wolfgang Siegert; Jörg Beyer
Chemotherapy in patients with metastatic or relapsed germ-cell tumours.
Cancer treatment reviews 2001;27(5):283-8.
2001: Christian Görg; B Wollenberg; Jörg Beyer
Reversed portal vein pulsatility on Doppler ultrasound secondary to an iatrogenic mediastinal haematoma.
The British journal of radiology 2001;74(886):962-4.
2001: Oliver Rick; Jörg Beyer; Nimrod Schwella; H Schubart; Jan Schleicher; Wolfgang Siegert
Assessment of amifostine as protection from chemotherapy-induced toxicities after conventional-dose and high-dose chemotherapy in patients with germ cell tumor.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(8):1151-5.
2001: Dorothea Kingreen; Jörg Beyer; S Kleiner; Stefanie Reif; Dieter Huhn; Wolfgang Siegert
ICE--an efficient drug combination for stem cell mobilization and high-dose treatment of malignant lymphoma.
European journal of haematology. Supplementum 2001;64():46-50.
2001: Jörg Beyer; O Rick; Wolfgang Siegert; C Bokemeyer
Salvage chemotherapy in relapsed germ cell tumors.
World journal of urology 2001;19(2):90-3.
2001: C Schimmelpfennig; Ralph Naumann; T Zuberbier; Rainer Ordemann; H Baurmann; Jörg Beyer; Wolfgang Siegert; Martin Bornhäuser; Gerhard Ehninger
Skin involvement as the first manifestation of systemic aspergillosis in patients after allogeneic hematopoietic cell transplantation.
Bone marrow transplantation 2001;27(7):753-5.
2001: Carsten Bokemeyer; Jean Pierre Droz; Alan Horwich; Arthur Gerl; Sophie D Fossa; Jörg Beyer; Jörg Pont; Hans-J Schmoll; Lothar Kanz; Lawrence Einhorn; Craig Nichols; Jörg Thomas Hartmann
Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome.
Cancer 2001;91(7):1394-401.
2001: Jörg Thomas Hartmann; Lawrence Einhorn; Craig Nichols; Jean Pierre Droz; Alan Horwich; Arthur Gerl; Sophie D Fossa; Jörg Beyer; Jörg Pont; Hans-J Schmoll; Lothar Kanz; Carsten Bokemeyer
Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(6):1641-8.
2001: Oliver Rick; Nimrod Schwella; Jörg Beyer; Marc Dubiel; Andreas Krusch; Martin Hildebrandt; Jan Schleicher; Stefan Serke; Wolfgang Siegert
PBPC mobilization with paclitaxel, ifosfamide, and G-CSF with or without amifostine: results of a prospective randomized trial.
Transfusion 2001;41(2):196-200.
2001: Oliver Rick; Carsten Bokemeyer; Jörg Beyer; Jörg Thomas Hartmann; Nimrod Schwella; Dorothea Kingreen; S Neureither; Bernd Metzner; Jochen Casper; Hannes Wandt; F Hartmann; Hans-J Schmoll; Günter Derigs; Arthur Gerl; Wolfgang E Berdel; Lothar Kanz; Wolfgang Siegert
Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(1):81-8.
2000: Winfried V Kern; Jörg Beyer; Angelika Böhme; Dieter Buchheidt; Oliver A Cornely; Hermann Einsele; Jens Kisro; William H Krüger; Georg Maschmeyer; Markus Ruhnke; C A Schmidt; S Schwartz; H Szelenyi
[Prophylaxis of infection in neutropenic patients. Guidelines of the Working Party on Infections in Hematology and Oncology].
Deutsche medizinische Wochenschrift (1946) 2000;125(51-52):1582-8.
2000: Oliver Rick; Jörg Beyer; Dorothea Kingreen; J S Kühl; Jürgen Zingsem; Dieter Huhn; Wolfgang Siegert; Nimrod Schwella
Successful autologous bone marrow rescue in patients who failed peripheral blood stem cell mobilization.
Annals of hematology 2000;79(12):681-6.
2000: Martin Hildebrandt; Oliver Rick; A Salama; Wolfgang Siegert; Dieter Huhn; Jörg Beyer
Detection of germ-cell tumor cells in peripheral blood progenitor cell harvests: impact on clinical outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(12):4641-6.
2000: Rainer Souchon; Susanne Krege; HJ Schmoll; Peter Albers; Jörg Beyer; Carsten Bokemeyer; Johannes Classen; Klaus-Peter Dieckmann; Michael Hartmann; Axel Heidenreich; Wolfgang Höltl; Sabine Kliesch; Kai Uwe Köhrmann; Markus Kuczyk; Heinz Schmidberger; Stefan Weinknecht; E Winter; Christian Wittekind; D D
[Interdisciplinary consensus on diagnosis and therapy of testicular tumors. Results of an update conference based on evidence-based medicine. German Testicular Cancer study Group (GTCSG)].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2000;176(9):388-405.
2000: Christian Kollmannsberger; Arthur Gerl; Norbert Schleucher; Jörg Beyer; Markus Kuczyk; Oliver Rick; Jochen Casper; M Sosada; C Rie; Lothar Kanz; Carsten Bokemeyer
Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancer.
Anti-cancer drugs 2000;11(7):535-9.
2000: Thomas K Held; Dominique Krüger; A R Switala; Jörg Beyer; Dorothea Kingreen; C Busemann; Klaus Janitschke; Wolfgang Siegert
Diagnosis of toxoplasmosis in bone marrow transplant recipients: comparison of PCR-based results and immunohistochemistry.
Bone marrow transplantation 2000;25(12):1257-62.
2000: Jörg Thomas Hartmann; Craig Nichols; Jean Pierre Droz; Alan Horwich; Arthur Gerl; Sophie D Fossa; Jörg Beyer; Jörg Pont; Lawrence Einhorn; Lothar Kanz; Carsten Bokemeyer
The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors.
Cancer 2000;88(11):2629-35.
2000: Christian Kollmannsberger; Craig Nichols; D D; Jörg Thomas Hartmann; Norbert Schleucher; Jörg Beyer; P Schöfski; Günter Derigs; U Rüther; I Böhlke; Hans-J Schmoll; Lothar Kanz; Carsten Bokemeyer
First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastases.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(5):553-9.
2000: Jörg Thomas Hartmann; Craig Nichols; Jean Pierre Droz; Alan Horwich; Arthur Gerl; Sophie D Fossa; Jörg Beyer; Jörg Pont; Karim Fizazi; Lawrence Einhorn; Lothar Kanz; Carsten Bokemeyer
Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors.
Journal of the National Cancer Institute 2000;92(1):54-61.
1999: Carsten Bokemeyer; Christian Kollmannsberger; Andreas Harstrick; Jörg Beyer; Arthur Gerl; Jochen Casper; Bernd Metzner; Jörg Thomas Hartmann; Hans-J Schmoll; Lothar Kanz
Treatment of patients with cisplatin-refractory testicular germ-cell cancer. German Testicular Cancer Study Group (GTCSG).
International journal of cancer. Journal international du cancer 1999;83(6):848-51.
1999: Oliver Rick; Wolfgang Siegert; Jörg Beyer
High-dose salvage chemotherapy. Germ-cell tumor treatment results in Germany.
International journal of cancer. Journal international du cancer 1999;83(6):839-40.
1999: Carsten Bokemeyer; Christian Kollmannsberger; Christoph Meisner; Andreas Harstrick; Jörg Beyer; Bernd Metzner; Jörg Thomas Hartmann; Hans-J Schmoll; Lawrence Einhorn; Lothar Kanz; Craig Nichols
First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(11):3450-6.
1999: Stefan Schwartz; G Behre; Volker Heinemann; H Wandt; Elmar Schilling; M Arning; A Trittin; WV Kern; O Boenisch; D Bosse; K Lenz; Wolf-Dieter Ludwig; Wolfgang Hiddemann; W Siegert; Jörg Beyer
Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergillus infections during prolonged neutropenia: results of a prospective randomized multicenter trial.
Blood 1999;93(11):3654-61.
1999: Carsten Bokemeyer; Arthur Gerl; Patrick Schöffski; Andreas Harstrick; N Niederle; Jörg Beyer; Jochen Casper; Hans-J Schmoll; Lothar Kanz
Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):512-6.
1998: Wolfgang Siegert; Oliver Rick; Jörg Beyer
High-dose chemotherapy for salvage treatment of germ cell tumors: Charité, Virchow Klinikum, Berlin.
Bone marrow transplantation 1998;22 Suppl 4():S7-9.
1998: Oliver Rick; Jörg Beyer; Dorothea Kingreen; Nimrod Schwella; Andreas Krusch; Jan Schleicher; A Kirsch; Dieter Huhn; Wolfgang Siegert
High-dose chemotherapy in germ cell tumours: a large single centre experience.
European journal of cancer (Oxford, England : 1990) 1998;34(12):1883-8.
1998: Martin Hildebrandt; F Bläser; Jörg Beyer; W Siegert; M Y Mapara; D Huhn; A Salama
Detection of tumor cells in peripheral blood samples from patients with germ cell tumors using immunocytochemical and reverse transcriptase-polymerase chain reaction techniques.
Bone marrow transplantation 1998;22(8):771-5.
1998: Christian Kollmannsberger; Jörg Beyer; Jean Pierre Droz; Andreas Harstrick; Jörg Thomas Hartmann; Pierre Biron; Aude Fléchon; Patrick Schöffski; Markus Kuczyk; Hans-J Schmoll; Lothar Kanz; Carsten Bokemeyer
Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(10):3386-91.
1998: Wolfgang Siegert; Jörg Beyer; Dorothea Kingreen; R Blasczyk; H Baurmann; Nimrod Schwella; Jan Schleicher; A Kirsch; Dieter Huhn
Treatment of relapse after allogeneic bone marrow transplantation with unmanipulated G-CSF-mobilized peripheral blood stem cell preparation.
Bone marrow transplantation 1998;22(6):579-83.
1998: Wolfgang Siegert; Oliver Rick; Jörg Beyer
High-dose chemotherapy with autologous stem cell support in poor-risk germ cell tumors.
Annals of hematology 1998;76(5):183-8.
1998: Carsten Bokemeyer; Andreas Harstrick; Jörg Beyer; Bernd Metzner; U Rüther; J T Hartmann; K Holstein; Hans Günter Derigs; R de Wit; J Casper; Patrick Schöffski; I Kührer; Hans-Jochen Illiger; B Kempf; A Reichle; A Föller; Dieter K Hossfeld; J T Fischer; W E Berdel; H H Gerhartz; H Kirchner; K H Pflüger; Helmut Ostermann; Lothar Kanz; H J Schmoll
The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
Seminars in oncology 1998;25(2 Suppl 4):24-32; discussion 45-8.
1998: Wolfgang Siegert; Jörg Beyer
Germ cell tumors: dose-intensive therapy.
Seminars in oncology 1998;25(2):215-23.
1998: Hans-Joachim Schmoll; Jörg Beyer
Prognostic factors in metastatic germ cell tumors.
Seminars in oncology 1998;25(2):174-85.
1998: Carsten Bokemeyer; Jörg Thomas Hartmann; Markus A Kuczyk; M C Truss; Christian Kollmannsberger; Jörg Beyer; Udo Jonas; Lothar Kanz
Recent strategies for the use of paclitaxel in the treatment of urological malignancies.
World journal of urology 1998;16(2):155-62.
1998: Stefan Serke; Jörg Beyer; Oliver Rick; Nimrod Schwella; O Meyer; M Hildebrandt; Dieter Huhn
Analysis of CD34-expressing cells in clinical practice.
Vox sanguinis 1998;74 Suppl 2():469-75.
1997: Dorothea Kingreen; A Nitsche; Jörg Beyer; Wolfgang Siegert
Herpes simplex infection of the jejunum occurring in the early post-transplantation period.
Bone marrow transplantation 1997;20(11):989-91.
1997: Jörg Pont; Wolfgang Höltl; Lothar Weissbach; Jörg Beyer; Wolfgang Siegert
[High-dose chemotherapy and reinfusion of hematopoietic stem cells in advanced germ cells tumors with poor prognosis--the position in 1996].
Der Urologe. Ausg. A 1997;36(6):561-4.
1997: Jörg Beyer; Oliver Rick; Stefan Weinknecht; Dorothea Kingreen; K Lenz; Wolfgang Siegert
Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome.
Bone marrow transplantation 1997;20(10):813-9.
1997: D D; HJ Schmoll; Lothar Weissbach; Jörg Beyer; Carsten Bokemeyer; A Harstrick; Wolfgang Höltl; Rainer Souchon; H Vogler
[An interdisciplinary consensus conference on the diagnosis and therapy of testicular tumors].
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1997;173(8):397-406.
1997: Jörg Beyer; Dorothea Kingreen; M Krause; Jan Schleicher; I Schwaner; Nimrod Schwella; Dieter Huhn; Wolfgang Siegert
Long-term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy.
Cancer 1997;79(1):161-8.
1996: Jörg Beyer; A Kramar; R Mandanas; W Linkesch; A Greinix; J P Droz; J L Pico; A Diehl; Carsten Bokemeyer; H J Schmoll; Craig Nichols; L H Einhorn; Wolfgang Siegert
High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(10):2638-45.
1996: Jörg Beyer; W Siegert
Prognosis after high-dose chemotherapy in patients with germ cell tumors.
Bone marrow transplantation 1996;18 Suppl 1():S61-2.
1996: Wolfgang Siegert; Jörg Beyer
High-dose chemotherapy and ASCR of patients with relapsed or refractory germ cell tumors: long-term follow-up.
Bone marrow transplantation 1996;18 Suppl 1():S60.
1996: Nimrod Schwella; Jörg Beyer; Hans-Gert Heuft; Oliver Rick; I Schwaner; Stefan Serke; Dieter Huhn; Wolfgang Siegert
Value of preapheresis cell counts on PBPC harvest and effect of reinfused cell dose on engraftment.
Bone marrow transplantation 1996;18 Suppl 1():S8-9.
1996: Nimrod Schwella; Jörg Beyer; I Schwaner; Hans-Gert Heuft; Oliver Rick; Dieter Huhn; Stefan Serke; Wolfgang Siegert
Impact of preleukapheresis cell counts on collection results and correlation of progenitor-cell dose with engraftment after high-dose chemotherapy in patients with germ cell cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(4):1114-21.
1996: Carsten Bokemeyer; Jörg Beyer; Bernd Metzner; U Ruther; Andreas Harstrick; L Weissbach; U Kohrmann; W Verbeek; H J Schmoll
Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(1):31-4.
1996: Carsten Bokemeyer; Jörg Thomas Hartmann; M A Kuczyk; Michael C Truss; Jörg Beyer; Udo Jonas; Lothar Kanz
The role of paclitaxel in chemosensitive urological malignancies: current strategies in bladder cancer and testicular germ-cell tumors.
World journal of urology 1996;14(6):354-9.
1995: Nimrod Schwella; Wolfgang Siegert; Jörg Beyer; Oliver Rick; Jürgen Zingsem; Reinhold Eckstein; Stefan Serke; Dieter Huhn
Autografting with blood progenitor cells: predictive value of preapheresis blood cell counts on progenitor cell harvest and correlation of the reinfused cell dose with hematopoietic reconstitution.
Annals of hematology 1995;71(5):227-34.
1995: Jörg Beyer; Nimrod Schwella; Jürgen Zingsem; I Strohscheer; I Schwaner; Helmut Oettle; Stefan Serke; Dieter Huhn; W Stieger
Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(6):1328-35.
1995: C Bokemeyer; H J Schmoll; M A Kuczyk; Jörg Beyer; W Siegert
Risk of secondary leukemia following high cumulative doses of etoposide during chemotherapy for testicular cancer.
Journal of the National Cancer Institute 1995;87(1):58-60.
1994: Wolfgang Siegert; Jörg Beyer; I Strohscheer; H Baurmann; Helmut Oettle; Jürgen Zingsem; R Zimmermann; C Bokemeyer; H J Schmoll; Dieter Huhn
High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(6):1223-31.
1994: Jörg Beyer; S Schwartz; V Heinemann; W Siegert
Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patients.
Antimicrobial agents and chemotherapy 1994;38(5):911-7.
1994: Jörg Beyer; S Schwartz; G Barzen; G Risse; K Dullenkopf; C Weyer; W Siegert
Use of amphotericin B aerosols for the prevention of pulmonary aspergillosis.
Infection 1994;22(2):143-8.
1994: J Oertel; B Oertel; Jörg Beyer; Dieter Huhn
CD 34 immunotyping of blasts in myelodysplasia.
Annals of hematology 1994;68(2):77-80.
1994: I Strohscheer; Jörg Beyer; K Lenz; Jürgen Zingsem; Volker Weisbach; Dieter Huhn; Reinhold Eckstein
[Distinct lymphocyte reactivity in multivariate test systems and dependence on the HLA system].
Beiträge zur Infusionstherapie und Transfusionsmedizin = Contributions to infusion therapy and transfusion medicine 1994;32():297-9.
1994: Jürgen Zingsem; Volker Weisbach; Robert Zimmermann; T Zeiler; H Mitschulat; Jörg Beyer; Reinhold Eckstein
Automated bone marrow concentration using the Fresenius AS 104 blood cell separator.
Beiträge zur Infusionstherapie und Transfusionsmedizin = Contributions to infusion therapy and transfusion medicine 1994;32():355-9.
1994: Nimrod Schwella; Robert Zimmermann; Hans-Gert Heuft; R Blasczyk; Jörg Beyer; Oliver Rick; C Kreissig; Jürgen Zingsem; Reinhold Eckstein; Wolfgang Siegert
Microbiologic contamination of peripheral blood stem cell autografts.
Vox sanguinis 1994;67(1):32-5.
1994: Jörg Beyer; C Bokemeyer; H J Schmoll; W Siegert
Treatment intensification in disseminated germ-cell tumors.
World journal of urology 1994;12(4):207-13.
1994: Carsten Bokemeyer; H J Schmoll; F Natt; M Knoche; Jörg Beyer; Rainer Souchon
Preliminary results of a phase I/II trial of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer.
Journal of cancer research and clinical oncology 1994;120(12):754-7.
1993: Carsten Bokemeyer; H J Schmoll; Bernd Metzner; Jörg Beyer; Hans-Jochen Illiger; M Kneba; Helmut Ostermann; B Kynast; U Räth; H Poliwoda
Comparison of 5 vs 10 micrograms/kg per day of GM-CSF following dose-intensified chemotherapy with cisplatin, etoposide, and ifosfamide in patients with advanced testicular cancer.
Annals of hematology 1993;67(2):75-9.
1993: Jörg Beyer; G Barzen; G Risse; C Weyer; K Miksits; K Dullenkopf; D Huhn; W Siegert
Aerosol amphotericin B for prevention of invasive pulmonary aspergillosis.
Antimicrobial agents and chemotherapy 1993;37(6):1367-9.
1993: K Miksits; Jörg Beyer; W Siegert
Serum concentrations of G-CSF during high-dose chemotherapy with autologous stem cell rescue.
Bone marrow transplantation 1993;11(5):375-7.
1993: Jürgen Zingsem; T Zeiler; R Zimmermanm; Volker Weisbach; H Mitschulat; H Schmid; Jörg Beyer; Wolfgang Siegert; Reinhold Eckstein
Automated processing of human bone marrow grafts for transplantation.
Vox sanguinis 1993;65(4):293-9.
1992: Jörg Beyer; R Schwerdtfeger; W Siegert
Graft-versus-host disease or graft-versus-host-like syndrome.
Blood 1992;80(11):2948-50.
1992: Jörg Beyer; J Grabbe; K Lenz; Volker Weisbach; I Strohscheer; Dieter Huhn; Wolfgang Siegert
Cutaneous toxicity of high-dose carboplatin, etoposide and ifosfamide followed by autologous stem cell reinfusion.
Bone marrow transplantation 1992;10(6):491-4.
1992: Reinhold Eckstein; I Strohscheer; Jörg Beyer; K Lenz; G Wittmann; Jürgen Zingsem; Volker Weisbach; Dieter Huhn; W Mempel
[Attempts in developing a standardized test system of immunologic reactivity].
Beiträge zur Infusionstherapie = Contributions to infusion therapy 1992;30():332-7.
1991: Jürgen Zingsem; T Zeiler; Volker Weisbach; C Holfeld-Ozuysal; Robert Zimmermann; Hans-Gert Heuft; Jörg Beyer; R Schwerdtfeger; Reinhold Eckstein
[Clinical use of peripheral stem cells for autologous transplantation].
Beiträge zur Infusionstherapie = Contributions to infusion therapy 1991;28():251-3.